Cory Weissman is a Psychiatry physician affiliated with San Diego State University. OpenAlex indexes 73 publications with 1,167 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
100%Benzodiazepine55.6%Clonazepam100%Part D<11 patientsOther antidepressants44.4%Mirtazapine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
- Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI
University of California, San Diego
FY2026$197,521K23MH138746 - Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI
University of California, San Diego
FY2025$197,576K23MH138746 - Cortical Inhibition as a Biomarker of Response in a Comparison of Bilateral versus Unilateral Accelerated Theta Burst Stimulation for Suicidal Ideation in Treatment-Resistant Depression -COMBAT-SI
University of California, San Diego
FY2024$197,576K23MH138746
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Keith Joseph Horvath
San Diego State University
Edith Lederman, MD, MPH
San Diego State University
Zhijie Wang
San Diego State University
Francisco Pardo, MD
San Diego State University
Charles Nemeroff, MD
Dell Medical School
Dennis Charney, MD
Icahn School of Medicine at Mount Sinai
Maurizio Fava, MD
Massachusetts General Hospital
John Krystal, MD
Yale University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”